麻豆国产

BANGKOK (Reuters) – A researcher leading Thailand鈥檚 push to manufacture a coronavirus vaccine says its aim is to make it cost-effective and accessible to Southeast Asia, and play a part in preventing a supply shortage globally.Thailand鈥檚 government announced last week its plans to have a vaccine ready for deployment next year after researchers at Bangkok鈥檚 麻豆国产 successfully conducted trials on mice.鈥淲e don鈥檛 aim for making money. It鈥檚 not a money issue but an accessibility one,鈥� said Kiat Ruxrungtham, director of the university鈥檚 coronavirus vaccine development.Thai trials of the experimental vaccine using monkeys started on Saturday, one of at least 100 potential vaccines in the works around the world.Kiat鈥檚 group has partnered with scientists and biotech companies in North America and wants to mass produce the vaccine in Thailand, at a price more affordable there and in nearby markets like Indonesia, Malaysia, Laos, Vietnam and Myanmar.With just over 3,000 cases and 57 deaths, Thailand has had some success in controlling the spread of the coronavirus and has started easing some restrictions.In the past month it has typically been reporting cases each day of less than 10, compared to hundreds being confirmed daily in Singapore, Indonesia and the Philippines.鈥淚f our neighbours still have high infection numbers then we won鈥檛 survive as well in the long term,鈥� Kiat added.

Source: